| David W Stevens, MD | |
|
1551 Renaissance Towne Dr, Ste. 400, Bountiful, UT 84010-7667 | |
| (801) 295-7200 | |
| (801) 295-4930 |
| Full Name | David W Stevens |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 24 Years |
| Location | 1551 Renaissance Towne Dr, Bountiful, Utah |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902941479 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 6120782-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Lakeview Hospital | Bountiful, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanner Memorial Clinic | 4284547985 | 211 |
News Archive
Eisai Corporation of North America has announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen(R) (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia.
Lpath, Inc., the category leader in lipidomics-based therapeutics, demonstrated commercially acceptable yields in its optimized fermentation process. In doing so, Lpath achieved one of four Phase 1 objectives established by Merck Serono, the exclusive worldwide licensee of ASONEP and Lpath's development partner, and will receive a milestone payment according to the terms of the Merck Serono license agreement.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
Long-term daily use of multivitamins could help to reduce the risk of cataracts, but has no effect on the risk of visually significant age-related macular degeneration, suggests research.
Children with depression admitted to the hospital for other illnesses like pneumonia, appendicitis or seizure disorders, stay longer, pay more and are at greater risk of death, a Rutgers New Jersey Medical School study finds.
› Verified 7 days ago
| Entity Name | Tanner Memorial Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447239355 PECOS PAC ID: 4284547985 Enrollment ID: O20031110000132 |
News Archive
Eisai Corporation of North America has announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen(R) (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia.
Lpath, Inc., the category leader in lipidomics-based therapeutics, demonstrated commercially acceptable yields in its optimized fermentation process. In doing so, Lpath achieved one of four Phase 1 objectives established by Merck Serono, the exclusive worldwide licensee of ASONEP and Lpath's development partner, and will receive a milestone payment according to the terms of the Merck Serono license agreement.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
Long-term daily use of multivitamins could help to reduce the risk of cataracts, but has no effect on the risk of visually significant age-related macular degeneration, suggests research.
Children with depression admitted to the hospital for other illnesses like pneumonia, appendicitis or seizure disorders, stay longer, pay more and are at greater risk of death, a Rutgers New Jersey Medical School study finds.
› Verified 7 days ago
| Entity Name | David W Stevens Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376722579 PECOS PAC ID: 1658468152 Enrollment ID: O20071031000157 |
News Archive
Eisai Corporation of North America has announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen(R) (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia.
Lpath, Inc., the category leader in lipidomics-based therapeutics, demonstrated commercially acceptable yields in its optimized fermentation process. In doing so, Lpath achieved one of four Phase 1 objectives established by Merck Serono, the exclusive worldwide licensee of ASONEP and Lpath's development partner, and will receive a milestone payment according to the terms of the Merck Serono license agreement.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
Long-term daily use of multivitamins could help to reduce the risk of cataracts, but has no effect on the risk of visually significant age-related macular degeneration, suggests research.
Children with depression admitted to the hospital for other illnesses like pneumonia, appendicitis or seizure disorders, stay longer, pay more and are at greater risk of death, a Rutgers New Jersey Medical School study finds.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David W Stevens, MD 1551 Renaissance Towne Dr, Ste. 400, Bountiful, UT 84010-7667 Ph: (801) 295-7200 | David W Stevens, MD 1551 Renaissance Towne Dr, Ste. 400, Bountiful, UT 84010-7667 Ph: (801) 295-7200 |
News Archive
Eisai Corporation of North America has announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen(R) (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia.
Lpath, Inc., the category leader in lipidomics-based therapeutics, demonstrated commercially acceptable yields in its optimized fermentation process. In doing so, Lpath achieved one of four Phase 1 objectives established by Merck Serono, the exclusive worldwide licensee of ASONEP and Lpath's development partner, and will receive a milestone payment according to the terms of the Merck Serono license agreement.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
Long-term daily use of multivitamins could help to reduce the risk of cataracts, but has no effect on the risk of visually significant age-related macular degeneration, suggests research.
Children with depression admitted to the hospital for other illnesses like pneumonia, appendicitis or seizure disorders, stay longer, pay more and are at greater risk of death, a Rutgers New Jersey Medical School study finds.
› Verified 7 days ago
Robert W Jordan, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1551 S Renaissance Towne Dr, #400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Paul Johnson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Lyle Beyer Mason, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1708 Stone Ridge Cir, Bountiful, UT 84010 Phone: 801-295-7604 Fax: 801-295-7604 | |
Travis M Hendry, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Ryan Paul Rigby, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010 Phone: 801-712-4204 Fax: 801-295-4930 | |
R Pepper Murray, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr, Ste. 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Dr. Jared John Tyson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr, Suite 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 |